Patents Examined by K. Carlson
  • Expression and use of human fibroblast growth factor receptor
    Patent number: 5229501
    Abstract: A new receptor for fibroblast growth factor has been cloned and expressed. The recombinant receptor is useful for inhibiting FGF activity, and for screening compounds for binding activity similar to that of FGF. A soluble, truncated recombinant receptor is also prepared, and is capable of binding FGF.
    Type: Grant
    Filed: January 11, 1991
    Date of Patent: July 20, 1993
    Assignee: Chiron Corporation
    Inventors: Michael C. Keifer, Pablo D. T. Valenzuela, Philip J. Barr